Patent intelligence · US
US 8403844
Methods for interventions
Methods for interventions
Patent details — US 8403844
- Jurisdiction
- US
- Status
- granted
- Grant date
- Mar 26, 2013
- Expiration
- Mar 21, 2033
- Applicant
- BioMarker Pharmaceuticals, Inc.
- Claims
- 11
- CPC classes
- A61K, A61K49/0004
Quick answer
US 8403844 (Methods for interventions) is held by BioMarker Pharmaceuticals, Inc.. Status: granted. Granted Mar 26, 2013. Expires Mar 21, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BioMarker Pharmaceuticals, Inc.
- Grant date
- Expiration
- Claims
- 11
- CPC classes
- A61K, A61K49/0004
More from BioMarker Pharmaceuticals, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12077601
Antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) and related methods
granted -
US 11885817
Biomarkers and methods for detection of seizures and epilepsy
granted -
US 11692030
Biomarkers and methods for detection of seizures and epilepsy
granted -
US 11598782
Biomarkers and methods for detection of seizures and epilepsy
granted -
US 11447500
Thienopyridine derivatives and pharmaceutical composition comprising same
granted -
US 11186873
Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET)
granted -
US 11078298
Antibodies to ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) and related methods
granted -
US 11008622
Biomarker for predicting sensitivity to EGFR-targeting agent, and use thereof
granted
Frequently asked questions
What is US patent 8403844?
US 8403844 (Methods for interventions) is held by BioMarker Pharmaceuticals, Inc.. Status: granted. Granted Mar 26, 2013. Expires Mar 21, 2033 (7 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8403844?
BioMarker Pharmaceuticals, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 27 pharmaceutical patents for this assignee.
When does US 8403844 expire?
Our index shows an expiration date of Mar 21, 2033 (7 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.